Indian Patent Law | Intellepedia

No Territorial Jurisdiction, No Quia Timet Relief: Lessons from a Patent Case

A stylized laboratory scene showing a large blue capsule being constructed by steampunk-style mechanical arms, with sparks flying. A wooden sign next to the capsule reads "UNDER CONSTRUCTION," symbolizing a drug still in development. Various lab equipment is visible in the background.

In the case of Helsinn Healthcare SA vs AET Laboratories, the Delhi High Court declined to entertain a patent infringement action filed in anticipation of future infringement. The Court examined the territorial reach of Indian courts in web-based patent matters and reaffirmed the principles required to sustain quia timet actions.

CRI Patentability Affirmed: Madras High Court Rules in Favor of Syngene

Illustration of a legal decision on computer-related inventions: code snippet on the left, legal gavel and scales on the right, with the title 'Madras HC Reboots Computer-Related Invention Refusal' in the center.

Madras HC upholds CRI patentability in Syngene’s case, ruling novel hardware isn’t a prerequisite for protection under Section 3(k).

Non-Disclosure of Prior Art in Hearing Notice Violates Natural Justice, Rules Delhi High Court

3D illustration of repeating blue molecular structures representing chemical compounds, symbolizing scientific formulations or agrochemical compositions.

In Croda Inc. v. Controller of Patents, the Delhi High Court emphasized procedural fairness and ruled that the non-disclosure of prior art in a hearing notice constitutes a breach of natural justice. The Court remanded the case for fresh evaluation.

Pharmacyclics Divisional Patent Application Upheld by Calcutta High Court

3D molecular structures illustrating chemical bonding and a detailed fluorinated organic compound model with carbon, hydrogen, oxygen, nitrogen, and fluorine atoms

Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.

Amgen’s Lyophilized Peptibody Patent Upheld by Madras High Court

Banner with lab test tubes and a microscope; text reads 'Amgen’s Peptibody Patent Refusal Overturned' following Madras High Court ruling

Madras High Court backs Amgen on lyophilized peptibody formulations, rejecting Section 3(d), 3(e) and inventive step objections. Grant directed, with claims narrowed to supported sequences.

Delhi High Court Patent Injunction: Aquestia Wins Against Automat Industries

A 3D-rendered digital image depicting a legal and engineering theme. The foreground shows a judge's gavel resting on legal documents with metal fittings and coins scattered nearby. In the background, mechanical valve systems are integrated with justice scales, symbolizing a legal dispute over industrial components, likely fluid control valves. The scene combines elements of law and technology, representing a patent conflict or court ruling in an engineering context.

Delhi High Court grants patent injunction to Aquestia, stopping Automat from selling Hydromat valves over suspected patent infringement.

Squibb Secures Interim Injunction Against Zydus in Nivolumab Patent Dispute

Laboratory pipette with DNA and molecular structures representing biotech research

The Delhi High Court has issued an interim injunction restraining Zydus from launching its Nivolumab biosimilar, siding with Squibb’s claim of imminent patent infringement.

Delhi HC Remands Oxidation Process Patent Rejection, Cites Invalid Section 2(1)(j) and 59 Findings

Green chalkboard with various hand-drawn organic chemistry structures and chemical equations, including benzene rings, hydroxyl groups, and molecular formulas like N₂ + 3H₂ → 2NH₃, representing chemical reactions and compounds.

In the case of Treibacher Industrie AG v. Assistant Controller of Patents, the Delhi High Court set aside the refusal of a patent application for a catalytic oxidation process. It held that the amended claims qualified as a process invention and were within the permissible scope of amendment under Section 59.

Court Awards ₹50 Lakh to GSP Crop Science in Patent Infringement Case Over Agrochemical Formula

Wooden letter tiles arranged to spell "SELLER LIABILITY," highlighting the concept of seller liability in Patent infringement cases

Delhi HC orders ₹50 lakh in damages to GSP Crop Science for patent infringement in agrochemicals, affirming seller liability under Indian patent law.

Patented Biologics and Section 104A: No Process Disclosure Without Proving Product Identity

An image with the title "Biosimilars & Section 104A" written in a mixed-font, ransom-note style on a blue background. To the right, various colorful pills and tablets are spilling out of an orange prescription pill bottle.

Roche sued Zydus for infringing its process patent on Pertuzumab. The Delhi High Court held that Roche had not shown Zydus’s biosimilar was identical to its product. Without identity, Section 104A did not apply, and the Court refused to compel Zydus to disclose its manufacturing process.